Investigating how a specific chloride transporter affects brain function in models of psychiatric disorders
Official title: NKCC1-KCC2 system modulation in rodent models relevant for psychiatric disorders
Funded at Northwestern University at Chicago · NIH-11114186 · Data updated 2026-11-12
This study is looking at how a specific brain system affects thinking and social behavior in models of schizophrenia, and it tests whether a medication called bumetanide can help improve brain function and cognitive skills in people with this condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project start | July 20, 2024 |
| Project end | July 19, 2025 |
| Funding year | 2024 |
| Award (this year) | $647,833 |
| NIH project number | 1R56MH135860-01 |
| Project ID | NIH-11114186 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults diagnosed with schizophrenia or related neurodevelopmental disorders.
✕Less likely to help
Patients with psychiatric disorders not related to cognitive impairment may not benefit from this research.
What this research studies
This research explores the role of the NKCC1-KCC2 system in the brain, particularly how it influences cognitive function and social behavior in models of schizophrenia. By using rodent models treated with phencyclidine, which simulates cognitive impairment, the study examines how the balance of excitation and inhibition in the brain is disrupted. The researchers aim to determine if a drug called bumetanide can restore normal brain function and improve cognitive performance. This approach could lead to new treatment strategies for individuals with psychiatric disorders.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic options for improving cognitive function in patients with schizophrenia and related disorders.
How similar studies have gone: Previous research has shown promising results using similar approaches to restore cognitive function in animal models of psychiatric disorders.
Where this research is happening
-
Northwestern University at Chicago
Chicago, United States Active
Researchers
- Principal investigator: Martina, Marco — Northwestern University at Chicago
- Study coordinator: Martina, Marco
Related research
Other NIH-funded projects on the same topics.
-
Whole-chromosome fine-mapping across diverse ancestries to understand psychiatric disorders
A study to pinpoint the exact genetic changes that contribute to bipolar disorder and related conditions by using diverse populations to improve accuracy.
-
Neuronal signals guiding deep brain stimulation for neuropsychiatric disorders
A doctor-scientist at Stanford plans to study how deep brain stimulation changes brain cells and circuits in people with OCD, depression, and movement disorders to improve how DBS therapies work.
-
How a spouse's mental health and substance use may affect a partner's drinking problems
A study looks at how a spouse’s psychiatric disorders and drinking habits influence when a person starts, stops, or relapses into alcohol use problems within marriage.
-
Mapping brain microstructure in psychiatric disorders with normal ranges
A study will build a brain-mapping reference to understand how an individual’s brain differs within the normal range, with a focus on youths and how age and sex affect brain microstructure.
-
Foundation Models for Brain Imaging in Psychiatry
A large AI model will be trained on many brain scans and related data to help researchers understand ADHD, autism, and bipolar disorder.
-
How early pollution and stress change brain circuits for motivation and memory
This work looks at how early-life exposure to pollution and stress can alter brain circuits that control motivation and working memory for people with ADHD, depression, or similar conditions.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.